Investigación

HBV-COMSAVA

Hepatitis B Virus COMmunity Screening and Vaccination in Africans

Proyecto HBV-COMSAVA
Duración
01/12/2020 - 28/02/2022
Coordinador
Jeffrey Lazarus
Financiadores
Gilead Sciences HBV-CARE Program

The objective of this study is to use point-of-care diagnostics in community settings to identify and link to care African (Ghanaian and Senegalese who are living in the greater Barcelona area) migrants infected with the hepatitis B virus (HBV). Specifically, this pilot study will utilize a novel rapid diagnostic test to screen for HBsAg, the dried blood spot (DBS) testing method to collect blood samples and transport to the laboratory, and will offer decentralized vaccination when appropriate for those who do not already have immunity.

This project is led by ISGlobal in collaboration with west African community members, Hospital Clínic de Barcelona, Hospital Universitari Vall d'Hebron, the Health Department of the Generalitat de Catalunya, the Public Health Agency of Barcelona, and the Microbiology Department of the Vall d'Hebron Research Institute (VHIR).

Total Funding

€ 142,000

Nuestro equipo

Coordinator

ISGlobal Team

Otros proyectos

Ver proyectos pasados

COMBACTE

Combatiendo la Resistencia Bacteriana en Europa

COMBACTE-CARE

Combatting Bacterial Resistance in Europe - Carbapenem Resistance

Xpatial-TB

Improved case detection through TB contact risk stratification by Xpert results and spatial parameters in Mozambique

WHIP3TB

Evaluation of the effect of weekly high dose rifapentine and isoniazid (3HP) vs periodic 3HP vs 6H for preventing TB among HIV-positive individuals

VINCI

Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique

INTE-AFRICA

Integrating and decentralizing diabetes and hypertension services in Africa

AVATAR

Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.

COVID-PREG

Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo

AMR DetecTool

A breakthrough device for the rapid detection of antimicrobial resistance

ANTICOV

Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19

Stool4TB

Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV